JP2019502734A5 - - Google Patents

Download PDF

Info

Publication number
JP2019502734A5
JP2019502734A5 JP2018538167A JP2018538167A JP2019502734A5 JP 2019502734 A5 JP2019502734 A5 JP 2019502734A5 JP 2018538167 A JP2018538167 A JP 2018538167A JP 2018538167 A JP2018538167 A JP 2018538167A JP 2019502734 A5 JP2019502734 A5 JP 2019502734A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
formula
pharmaceutically acceptable
acceptable salt
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019502734A (ja
JP6929860B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/051133 external-priority patent/WO2017125523A1/en
Publication of JP2019502734A publication Critical patent/JP2019502734A/ja
Publication of JP2019502734A5 publication Critical patent/JP2019502734A5/ja
Application granted granted Critical
Publication of JP6929860B2 publication Critical patent/JP6929860B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538167A 2016-01-21 2017-01-20 手湿疹の治療 Active JP6929860B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16152215.6 2016-01-21
EP16152215 2016-01-21
PCT/EP2017/051133 WO2017125523A1 (en) 2016-01-21 2017-01-20 Treatment of hand eczema

Publications (3)

Publication Number Publication Date
JP2019502734A JP2019502734A (ja) 2019-01-31
JP2019502734A5 true JP2019502734A5 (cg-RX-API-DMAC10.html) 2020-02-27
JP6929860B2 JP6929860B2 (ja) 2021-09-01

Family

ID=55236207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018538167A Active JP6929860B2 (ja) 2016-01-21 2017-01-20 手湿疹の治療

Country Status (31)

Country Link
US (3) US20200397787A1 (cg-RX-API-DMAC10.html)
EP (2) EP4257205A3 (cg-RX-API-DMAC10.html)
JP (1) JP6929860B2 (cg-RX-API-DMAC10.html)
KR (2) KR20180102662A (cg-RX-API-DMAC10.html)
CN (3) CN117159553A (cg-RX-API-DMAC10.html)
AU (3) AU2017209932A1 (cg-RX-API-DMAC10.html)
BR (1) BR112018014769A2 (cg-RX-API-DMAC10.html)
CA (1) CA3010547A1 (cg-RX-API-DMAC10.html)
CY (2) CY1126388T1 (cg-RX-API-DMAC10.html)
DK (1) DK3405197T3 (cg-RX-API-DMAC10.html)
ES (1) ES2963784T3 (cg-RX-API-DMAC10.html)
FI (2) FI3405197T3 (cg-RX-API-DMAC10.html)
FR (1) FR24C1053I2 (cg-RX-API-DMAC10.html)
HR (1) HRP20231448T1 (cg-RX-API-DMAC10.html)
HU (2) HUE064192T2 (cg-RX-API-DMAC10.html)
IL (4) IL320757A (cg-RX-API-DMAC10.html)
LT (2) LT3405197T (cg-RX-API-DMAC10.html)
MX (2) MX394358B (cg-RX-API-DMAC10.html)
NL (1) NL301306I2 (cg-RX-API-DMAC10.html)
NO (1) NO2024058I1 (cg-RX-API-DMAC10.html)
PL (1) PL3405197T3 (cg-RX-API-DMAC10.html)
PT (1) PT3405197T (cg-RX-API-DMAC10.html)
RS (1) RS64798B1 (cg-RX-API-DMAC10.html)
RU (1) RU2018130097A (cg-RX-API-DMAC10.html)
SG (2) SG10202006830WA (cg-RX-API-DMAC10.html)
SI (1) SI3405197T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202300415T1 (cg-RX-API-DMAC10.html)
TW (2) TWI783921B (cg-RX-API-DMAC10.html)
UA (1) UA123780C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017125523A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201804098B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3968997T3 (fi) * 2019-05-15 2026-06-09 Leo Pharma As Delgositinibin formulaatio voiteen muodossa
CA3210150A1 (en) * 2021-02-02 2022-08-11 Pfizer Inc. Dosing regime for treatment of chronic hand eczema
KR20240027044A (ko) * 2021-07-30 2024-02-29 일라이 릴리 앤드 캄파니 바리시티닙을 사용한 손 습진의 치료
JP2026509302A (ja) 2023-03-17 2026-03-17 レオ ファーマ アクティーゼルスカブ 中等症ないし重症の慢性手湿疹を有する患者における慢性手湿疹を処置する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US20130302298A1 (en) * 2010-11-30 2013-11-14 Bio-K Plus International Inc. Treatment and prevention of eczema
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent

Similar Documents

Publication Publication Date Title
JP6356684B2 (ja) コルヒチン誘導体の投与による心血管イベントの処置または予防
RU2470642C2 (ru) Аналоги птерина для лечения состояния, чувствительного к вн4
JP2023022177A (ja) 治療用アプレミラスト局所組成物
JP2005343897A5 (cg-RX-API-DMAC10.html)
JP2014516942A5 (cg-RX-API-DMAC10.html)
JP2013511534A5 (cg-RX-API-DMAC10.html)
AU2022252766B2 (en) Treatment of hand eczema
EP4442321A3 (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor
JPH1036260A (ja) 抗ガン剤の効力増強方法
JP4929173B2 (ja) A2bアデノシンレセプターアンタゴニストを使用する創傷治癒の方法
ES2950492T3 (es) Nalmefeno para la reducción del consumo de alcohol en poblaciones objetivos específicas
JP2023531930A5 (cg-RX-API-DMAC10.html)
US10052328B2 (en) Therapeutic composition to treat lesions caused by Herpes Simplex Virus
EP2730271B1 (en) Aqeuous compositions
JP2008169155A (ja) 爪に対する薬物の浸透促進剤及びそれを含有する外用爪治療剤
JP2004262775A5 (cg-RX-API-DMAC10.html)
CN1761466A (zh) 慢性皮肤疾病的治疗及/或预防剂
JP2008231041A (ja) 末梢循環改善薬
AU2007265292A1 (en) An anti-viral composition for the topical treatment of Herpes Labialis (cold sores) and method for use thereof
RU2021136865A (ru) Лечение кожной формы красной волчанки
JP2006188496A (ja) p38MAPキナーゼ阻害剤を有効成分とする掻痒治療剤
CN101203222A (zh) 用于治疗湿疹的丙嗪或紧密相关的化合物
RU2000121830A (ru) Лекарственный препарат для лечения кожных болезней собак и кошек
HK1260652A1 (en) Use of delgocitinib for the treatment of chronic hand eczema
JP2010520213A5 (cg-RX-API-DMAC10.html)